BR112023019795A2 - Composições nasais compreendendo alcaftadina - Google Patents
Composições nasais compreendendo alcaftadinaInfo
- Publication number
- BR112023019795A2 BR112023019795A2 BR112023019795A BR112023019795A BR112023019795A2 BR 112023019795 A2 BR112023019795 A2 BR 112023019795A2 BR 112023019795 A BR112023019795 A BR 112023019795A BR 112023019795 A BR112023019795 A BR 112023019795A BR 112023019795 A2 BR112023019795 A2 BR 112023019795A2
- Authority
- BR
- Brazil
- Prior art keywords
- alcaftadine
- nasal
- nasal compositions
- pharmaceutically acceptable
- pharmaceutical composition
- Prior art date
Links
- MWTBKTRZPHJQLH-UHFFFAOYSA-N alcaftadine Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2CCN2C(C=O)=CN=C21 MWTBKTRZPHJQLH-UHFFFAOYSA-N 0.000 title abstract 3
- 229960001919 alcaftadine Drugs 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 206010028735 Nasal congestion Diseases 0.000 abstract 1
- 206010039085 Rhinitis allergic Diseases 0.000 abstract 1
- 230000000172 allergic effect Effects 0.000 abstract 1
- 201000010105 allergic rhinitis Diseases 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
composições nasais compreendendo alcaftadina. a presente invenção refere-se a uma composição farmacêutica nasal compreendendo alcaftadina ou um sal farmaceuticamente aceitável da mesma e, opcionalmente, um ou mais excipientes, métodos farmaceuticamente aceitáveis de tratamento de rinite alérgica, rinoconjutivite alérgica ou sintomas das mesmas (tais como congestão nasal) com a composição farmacêutica nasal, e métodos de preparar a mesma.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN202121015680 | 2021-04-01 | ||
PCT/IB2021/055221 WO2022208146A1 (en) | 2021-04-01 | 2021-06-14 | Nasal compositions comprising alcaftadine |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112023019795A2 true BR112023019795A2 (pt) | 2023-11-07 |
Family
ID=76523258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112023019795A BR112023019795A2 (pt) | 2021-04-01 | 2021-06-14 | Composições nasais compreendendo alcaftadina |
Country Status (11)
Country | Link |
---|---|
US (1) | US20240173331A1 (pt) |
EP (1) | EP4312973A1 (pt) |
JP (1) | JP2024512121A (pt) |
KR (1) | KR20230163413A (pt) |
CN (1) | CN117120029A (pt) |
AU (1) | AU2021437358A1 (pt) |
BR (1) | BR112023019795A2 (pt) |
CA (1) | CA3213156A1 (pt) |
CL (1) | CL2023002871A1 (pt) |
MX (1) | MX2023011546A (pt) |
WO (1) | WO2022208146A1 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11992493B1 (en) * | 2022-10-25 | 2024-05-28 | Liangdan Sun | Use of compound or pharmaceutical derivative thereof in inhibiting CaMK2G protein activity |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3877904D1 (de) | 1987-11-13 | 1993-03-11 | Asta Pharma Ag | Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge. |
IL101850A (en) | 1991-06-13 | 1996-01-31 | Janssen Pharmaceutica Nv | History 11-) 4-Pipridinyl (-Imidazo] B-1, 2 [] 3 [Benzazepine, their preparation and pharmaceutical preparations containing them |
PL1919450T3 (pl) | 2005-09-01 | 2014-11-28 | Meda Ab | Kompozycja liposomowa zawierająca lek przeciwhistaminowy i kortykosteroid oraz jej zastosowanie do wytwarzania leku do leczenia nieżytu nosa i chorób spokrewnionych |
EP2004196B1 (en) * | 2006-03-31 | 2016-06-29 | Vistakon Pharmaceuticals, LLC | Ocular allergy treatments |
CN102283849A (zh) | 2011-06-29 | 2011-12-21 | 北京阜康仁生物制药科技有限公司 | 一种含有阿卡他定的药物组合物 |
KR20140074881A (ko) * | 2011-06-29 | 2014-06-18 | 알러간, 인코포레이티드 | 두드러기의 치료에서 이용을 위한 알카프타딘 |
WO2019022225A1 (ja) | 2017-07-28 | 2019-01-31 | 参天製薬株式会社 | アルカフタジン又はその塩を含有する水性医薬組成物 |
CA3181959A1 (en) * | 2020-06-15 | 2021-12-23 | Alkem Laboratories Limited | Combination of alcaftadine and a corticosteroid |
-
2021
- 2021-06-14 WO PCT/IB2021/055221 patent/WO2022208146A1/en active Application Filing
- 2021-06-14 AU AU2021437358A patent/AU2021437358A1/en active Pending
- 2021-06-14 JP JP2023560146A patent/JP2024512121A/ja active Pending
- 2021-06-14 BR BR112023019795A patent/BR112023019795A2/pt unknown
- 2021-06-14 CA CA3213156A patent/CA3213156A1/en active Pending
- 2021-06-14 EP EP21733563.7A patent/EP4312973A1/en active Pending
- 2021-06-14 US US18/549,916 patent/US20240173331A1/en active Pending
- 2021-06-14 KR KR1020237033154A patent/KR20230163413A/ko unknown
- 2021-06-14 MX MX2023011546A patent/MX2023011546A/es unknown
- 2021-06-14 CN CN202180096503.1A patent/CN117120029A/zh active Pending
-
2023
- 2023-09-26 CL CL2023002871A patent/CL2023002871A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
US20240173331A1 (en) | 2024-05-30 |
CN117120029A (zh) | 2023-11-24 |
MX2023011546A (es) | 2023-10-06 |
JP2024512121A (ja) | 2024-03-18 |
CL2023002871A1 (es) | 2024-01-26 |
AU2021437358A1 (en) | 2023-09-14 |
WO2022208146A1 (en) | 2022-10-06 |
EP4312973A1 (en) | 2024-02-07 |
CA3213156A1 (en) | 2022-10-06 |
KR20230163413A (ko) | 2023-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP19083621A (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
NI201900099A (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
BR112014024672A8 (pt) | Composições farmacêuticas para terapia de combinação | |
ECSP18073366A (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
BR112017026159A2 (pt) | inibidores heterocíclicos de erk1 e erk2 e seu uso no tratamento de câncer | |
ECSP19083640A (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
CO2022014073A2 (es) | Compuestos antivirales y métodos para la administración de los mismos | |
BR112015029512A8 (pt) | derivados de pirazolopirrolidina, seus usos, e composição e combinação farmacêuticas | |
BRPI0507609A (pt) | combinações terapêuticas de anti-psicóticos atìpicos com antagonistas de fator de liberação de corticotropina | |
CR20190447A (es) | Derivados de indolina sustituidos como inhibidores de la replicación viral de dengue | |
BR112022024840A2 (pt) | Combinação de alcaftadina e um corticosteroide | |
BR112017011552A2 (pt) | derivados de fgf21 e seu uso | |
EA202191239A1 (ru) | Соединения и их применение для лечения дефицита 1-антитрипсина | |
BR112021021284A2 (pt) | Composto, composição farmacêutica, e, métodos para o tratamento ou profilaxia de doenças inflamatórias da pele, doenças respiratórias, doenças gastrointestinais, doenças oculares, cânceres, doenças reumáticas, doenças desmielinizantes e doenças fibróticas e de inibição da atividade de proteínas de bromodomínio e domínio terminal extra | |
BR112019018615A2 (pt) | compostos antimicrobianos, composições e usos dos mesmos | |
BR112021025764A2 (pt) | Derivado de pirimidina que inibe o crescimento de células cancerígenas e uso medicinal do mesmo | |
BR112023018472A2 (pt) | Composições de psilocibina, métodos de produção e métodos de uso das mesmas | |
BR112021018815A2 (pt) | Gepotidacina para uso no tratamento de infecções bacterianas do trato urinário | |
WO2018005801A3 (en) | Novel non-systemic tgr5 agonists | |
WO2018005794A3 (en) | Novel non-systemic tgr5 agonists | |
BR112023019795A2 (pt) | Composições nasais compreendendo alcaftadina | |
BR112019007863A2 (pt) | derivados de naftiridinona inovadores e seu uso no tratamento de arritmia | |
BR112018073419A2 (pt) | combinação, uso da combinação, método para o tratamento, composto, método para o tratamento de doença de alzheimer e composição farmacêutica | |
BR112019024804A2 (pt) | compostos bicíclicos 5,6-fundidos e composições para o tratamento de doenças parasíticas | |
BR112022012684A2 (pt) | Compostos cíclicos e métodos de uso dos mesmos |